Significance of Stereospecificity
The interaction of any chemical substance with a receptor strictly depends on its spatial structure, a phenomenon known as stereospecificity.
Many pharmacological agents possess stereoisomers—molecules that are mirror images of each other. Typically, only one isomer (most commonly the L-isomer) possesses the correct spatial orientation to bind maximally and effectively to the receptor's active site.
Classic examples include the atropine group of alkaloids:
- Hyoscyamine consists exclusively of the active L-isomer, allowing it to fit the receptor ideally.
- Atropine is produced via chemical extraction. During this process, a portion of the active L-isomer inevitably converts into the inactive D-isomer.
As a result, atropine is a racemate—a mixture of two isomers. Due to the presence of the "ballast" D-isomer, the pharmacological activity of atropine is exactly half that of pure hyoscyamine.
Structural Organization
Based on their cellular localization, receptors are divided into membrane receptors (embedded in the cell membrane) and intracellular receptors (located in the cytoplasm or nucleus).
Membrane receptors exhibit a clearly defined domain structure. Each domain performs a specific function in signal perception and transduction:
- Lipophilic domain: A transmembrane segment that spans the lipid bilayer and securely anchors the receptor.
- Hydrophilic domains: Divided into two groups:
- Extracellular domain: Faces outward and contains specific binding sites for ligands (substances that interact with the receptor).
- Intracellular domain: Projects into the cytoplasm, tasked with transmitting the received signal via interactions with effector systems.
Transmembrane Signal Transduction
The general mechanism of a membrane receptor involves a change in its shape. When a ligand binds to the extracellular domain, the receptor undergoes a conformational change. This structural shift is instantly transmitted to the intracellular domain, which subsequently affects effector proteins (enzymes or ion channels). In some cases, the receptor possesses intrinsic enzymatic activity.
The results of this activation include:
- Alteration of enzyme activity (increase or decrease).
- Opening or closing of ion channels.
- Initiation of a cascade of intracellular reactions leading to tissue, organ, and systemic effects.
Types of Receptors by Mechanism of Action
Based on how receptors interact with effector mechanisms, there are four main types of signal transduction:
- Intracellular receptors (Type 1). The ligand crosses the cell membrane. The ligand-receptor complex is transported to the nucleus, where it interacts with DNA. The primary function is the regulation of gene transcription.
- Enzyme-linked receptors (Type 2). Possess an intrinsic catalytic domain (e.g., tyrosine kinase). Their activation leads to direct phosphorylation of substrates.
- Ligand-gated ion channels (Type 3). The receptor forms an integral part of an ion channel pore. Ligand binding directly opens the pore for ion flux.
- G protein-coupled receptors (GPCRs; Type 4). The most complex signaling cascade. Interaction proceeds via the chain: Receptor — G protein — Effector protein. The ultimate outcome is an altered intracellular concentration of second messengers.